High-Sensitivity C-Reactive Protein Is Associated With Incident Type 2 Diabetes Among African Americans: The Jackson Heart Study
- PMID: 26068864
- PMCID: PMC4542275
- DOI: 10.2337/dc15-0221
High-Sensitivity C-Reactive Protein Is Associated With Incident Type 2 Diabetes Among African Americans: The Jackson Heart Study
Abstract
Objective: Previous studies on the association between hs-CRP and incident type 2 diabetes among African Americans have been inconclusive. We examined the association between hs-CRP and incident diabetes in a large African American cohort (Jackson Heart Study).
Research design and methods: hs-CRP was measured in 3,340 participants. Incident diabetes was defined by fasting glucose ≥126 mg/dL, physician diagnosis, use of diabetes drugs, or A1C ≥6.5% (48 mmol/mol) at follow-up. Cox regression was used to estimate hazard ratios (HRs) for incident diabetes, adjusting for age, sex, education, diabetes family history, alcohol, HDL, triglycerides, hypertension status, hypertension medications, physical activity, BMI, HOMA-insulin resistance (HOMAIR), and waist circumference.
Results: Participants (63% women) were aged 53.3 ± 12.5 years. During a median follow-up of 7.5 years, 17.4% developed diabetes (23.1/1,000 person-years, 95% CI 21.3-25.1). After adjustment, the HR (hs-CRP third vs. first tertile) was 1.64 (95% CI 1.26-2.13). In separate models, further adjustment for BMI and waist circumference attenuated this association (HR 1.28 [95% CI 0.97-1.69] and 1.35 [95% CI 1.03-1.78, P < 0.05 for trend], respectively). Upon adding HOMAIR in the models, the association was no longer significant. In adjusted HOMAIR-stratified analysis, the hs-CRP-diabetes association appeared stronger in participants with HOMAIR <3.0 compared with HOMAIR ≥3.0 (P < 0.0001 for interaction). The association was also stronger among nonobese participants, although not significant when adjusted for HOMAIR.
Conclusions: Low-grade inflammation, as measured by hs-CRP level, may have an important role in the development of diabetes among African Americans with a lesser degree of insulin resistance.
© 2015 by the American Diabetes Association. Readers may use this article as long as the work is properly cited, the use is educational and not for profit, and the work is not altered.
Figures
Similar articles
-
Associations of leptin and adiponectin with incident type 2 diabetes and interactions among African Americans: the Jackson heart study.BMC Endocr Disord. 2020 Mar 4;20(1):31. doi: 10.1186/s12902-020-0511-z. BMC Endocr Disord. 2020. PMID: 32131811 Free PMC article. Clinical Trial.
-
hs-CRP Is Associated With Incident Diabetic Nephropathy: Findings From the Jackson Heart Study.Diabetes Care. 2019 Nov;42(11):2083-2089. doi: 10.2337/dc18-2563. Epub 2019 Sep 11. Diabetes Care. 2019. PMID: 31511234 Free PMC article.
-
Metabolic syndrome in nondiabetic, obese, first-degree relatives of African American patients with type 2 diabetes: African American triglycerides-HDL-C and insulin resistance paradox.Ethn Dis. 2006 Autumn;16(4):830-6. Ethn Dis. 2006. PMID: 17061734
-
Building cultural competency for improved diabetes care: African Americans and diabetes.J Fam Pract. 2007 Sep;56(9 Suppl Building):S22-8. J Fam Pract. 2007. PMID: 18667136 Review.
-
Insulin resistance in African Americans.Kidney Int Suppl. 2003 Feb;(83):S27-30. doi: 10.1046/j.1523-1755.63.s83.7.x. Kidney Int Suppl. 2003. PMID: 12864871 Review.
Cited by
-
Prediction of Incident Diabetes in the Jackson Heart Study Using High-Dimensional Machine Learning.PLoS One. 2016 Oct 11;11(10):e0163942. doi: 10.1371/journal.pone.0163942. eCollection 2016. PLoS One. 2016. PMID: 27727289 Free PMC article.
-
Anti-inflammatory effects of empagliflozin in patients with type 2 diabetes and insulin resistance.Diabetol Metab Syndr. 2018 Dec 18;10:93. doi: 10.1186/s13098-018-0395-5. eCollection 2018. Diabetol Metab Syndr. 2018. PMID: 30574207 Free PMC article.
-
Association of C-Reactive Protein with Risk of Developing Type 2 Diabetes Mellitus, and Role of Obesity and Hypertension: A Large Population-Based Korean Cohort Study.Sci Rep. 2019 Mar 14;9(1):4573. doi: 10.1038/s41598-019-40987-8. Sci Rep. 2019. PMID: 30872696 Free PMC article.
-
Combined effect of adiposity and elevated inflammation on incident type 2 diabetes: a prospective cohort study.Cardiovasc Diabetol. 2023 Dec 20;22(1):351. doi: 10.1186/s12933-023-02067-0. Cardiovasc Diabetol. 2023. PMID: 38124083 Free PMC article.
-
Assessing the added predictive ability of a metabolic syndrome severity score in predicting incident cardiovascular disease and type 2 diabetes: the Atherosclerosis Risk in Communities Study and Jackson Heart Study.Diabetol Metab Syndr. 2018 May 16;10:42. doi: 10.1186/s13098-018-0344-3. eCollection 2018. Diabetol Metab Syndr. 2018. PMID: 29796112 Free PMC article.
References
-
- Centers for Disease Control and Prevention National Diabetes Statistics Report: Estimates of Diabetes and Its Burden in the United States, 2014. Atlanta, GA, U.S. Department of Health and Human Services, 2014
-
- Barzilay JI, Abraham L, Heckbert SR, et al. . The relation of markers of inflammation to the development of glucose disorders in the elderly: the Cardiovascular Health Study. Diabetes 2001;50:2384–2389 - PubMed
-
- Dehghan A, Kardys I, de Maat MP, et al. . Genetic variation, C-reactive protein levels, and incidence of diabetes. Diabetes 2007;56:872–878 - PubMed
-
- Festa A, D’Agostino R Jr, Tracy RP, Haffner SM; Insulin Resistance Atherosclerosis Study . Elevated levels of acute-phase proteins and plasminogen activator inhibitor-1 predict the development of type 2 diabetes: the insulin resistance atherosclerosis study. Diabetes 2002;51:1131–1137 - PubMed
-
- Freeman DJ, Norrie J, Caslake MJ, et al. .; West of Scotland Coronary Prevention Study . C-reactive protein is an independent predictor of risk for the development of diabetes in the West of Scotland Coronary Prevention Study. Diabetes 2002;51:1596–1600 - PubMed
Publication types
MeSH terms
Substances
Grants and funding
- HHSN268201300049C/PHS HHS/United States
- HHSN268201300048C/PHS HHS/United States
- R01 HL117285/HL/NHLBI NIH HHS/United States
- HHSN268201300047C/PHS HHS/United States
- HHSN268201300048C/HL/NHLBI NIH HHS/United States
- HHSN268201300049C/HL/NHLBI NIH HHS/United States
- HHSN268201300050C/PHS HHS/United States
- HHSN268201300046C/PHS HHS/United States
- HHSN268201300047C/HL/NHLBI NIH HHS/United States
- HHSN268201300050C/HL/NHLBI NIH HHS/United States
- R01-HL-117285/HL/NHLBI NIH HHS/United States
- HHSN268201300046C/HL/NHLBI NIH HHS/United States
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Research Materials
Miscellaneous